Skip to content
STOP-01

Chimeric Therapeutics Ltd (ASX: CHM) has announced a trading halt

Chimeric Therapeutics Ltd (ASX: CHM) has announced a trading halt.

There are a few reasons why a stock would go into a trading halt. It is generally ahead of a news announcement.

Chimeric Therapeutics Ltd has requested the trading halt pending the release of an announcement in relation to placement of shortfall under the Retail Entitlement Offer.

Trading halts are typically enacted in anticipation of a news announcement, to correct an order imbalance, as a result of a technical glitch or due to regulatory concerns.

Halts may also be triggered by severe down moves, in what are called circuit breakers or curbs.

The trading halt will remain in place until normal trading commences on March 25, 2022 or when the company announcement is made.

See more stories like this

download-the-app-today
0
    0
    Your Cart
    Your cart is emptyReturn to Shop
      Apply Coupon